Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × niraparib × 90 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 9 Neoplasms 4 Neoplasm Metastasis 4 Fallopian Tube Neoplasms 4 Breast Neoplasms 4 Prostatic Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Prostatic Neoplasms, Castration-Resistant 2 Pancreatic Neoplasms 2 Glioma 2 Glioblastoma 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Unilateral Breast Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 SCLC,Extensive Stage 1 Prostate Adenocarcinoma 1 Pathologic Complete Response 1 Osteosarcoma 1 Neuroblastoma 1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Metastatic Castration-sensitive Prostate Cancer 1 Lung Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Hemangiosarcoma 1 Endometrial Neoplasms 1 Disease Progression 1 Central Nervous System Neoplasms 1

Interventions

venetoclax 47 Rituximab 28 obinutuzumab 25 ibrutinib 25 Cyclophosphamide 25 acalabrutinib 22 fludarabine 21 pirtobrutinib 18 Specimen Handling 16 zanubrutinib 11 Biopsy 11 Bendamustine Hydrochloride 11 fludarabine phosphate 10 Magnetic Resonance Spectroscopy 8 Whole-Body Irradiation 6 Lenalidomide 6 idelalisib 5 Prednisone 5 Mycophenolic Acid 5 ARQ531 5 Vincristine 4 Tacrolimus 4 Doxorubicin 4 CT-P10 4 pembrolizumab 3 Stem Cell Transplantation 3 Peripheral Blood Stem Cell Transplantation 3 Granulocyte Colony-Stimulating Factor 3 Busulfan 3 Blood Component Removal 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡